[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @awakn_ls Solvonis Therapeutics plc Solvonis Therapeutics plc posts on X about $svns, $1b, $1225b, $700m the most. They currently have XXXXX followers and XXX posts still getting attention that total XX engagements in the last XX hours. ### Engagements: XX [#](/creator/twitter::1265596823818907648/interactions)  - X Week XXX -XX% - X Month XXXXX +1,849% - X Months XXXXX +30% - X Year XXXXX +66% ### Mentions: X [#](/creator/twitter::1265596823818907648/posts_active)  ### Followers: XXXXX [#](/creator/twitter::1265596823818907648/followers)  - X Week XXXXX -XXXX% - X Month XXXXX +0.11% - X Months XXXXX -XXXX% - X Year XXXXX -XXXX% ### CreatorRank: undefined [#](/creator/twitter::1265596823818907648/influencer_rank)  ### Social Influence [#](/creator/twitter::1265596823818907648/influence) --- **Social category influence** [currencies](/list/currencies) **Social topic influence** [$svns](/topic/$svns), [$1b](/topic/$1b), [$1225b](/topic/$1225b), [$700m](/topic/$700m), [$19b](/topic/$19b) ### Top Social Posts [#](/creator/twitter::1265596823818907648/posts) --- Top posts by engagements in the last XX hours "Solvonis is advancing SVN002 under the FDAs 505(b)(2) pathway referencing J&Js $1B+ blockbuster Spravato. SVN002 targets moderate-to-severe #AUD with a differentiated formulation for addiction clinics. #SVN002 #505b2 #Spravato #AddictionTreatment #Solvonis $SVNS"  [@awakn_ls](/creator/x/awakn_ls) on [X](/post/tweet/1946140765886800278) 2025-07-18 09:31:30 UTC 8583 followers, XXX engagements "AUD is the crisis we keep ignoring 29.5M Americans meet criteria for AUD X% get treatment. SVN002 is our neuroscience-led response: ✔ Novel esketamine therapeutic ✔ Clinic-based ✔ 505(b)(2) path bridging to Spravato #AUD #SVN002 #505b2 #AddictionTreatment #Solvonis"  [@awakn_ls](/creator/x/awakn_ls) on [X](/post/tweet/1945051660654350619) 2025-07-15 09:23:47 UTC 8581 followers, XXX engagements "Congrats to @SolvonisTx Chair Dennis Purcell on landmark $1.9B @AbbVieIGI deal As a Board Director at IGI he played a key role in one of biotechs biggest licensing agrmnts of 2025 🔹$700M upfront 🔹$1.225B in milestones 🔹Tiered royalties Proud to have him lead Solvonis"  [@awakn_ls](/creator/x/awakn_ls) on [X](/post/tweet/1944672838041960452) 2025-07-14 08:18:29 UTC 8581 followers, XXX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Solvonis Therapeutics plc posts on X about $svns, $1b, $1225b, $700m the most. They currently have XXXXX followers and XXX posts still getting attention that total XX engagements in the last XX hours.
Social category influence currencies
Social topic influence $svns, $1b, $1225b, $700m, $19b
Top posts by engagements in the last XX hours
"Solvonis is advancing SVN002 under the FDAs 505(b)(2) pathway referencing J&Js $1B+ blockbuster Spravato. SVN002 targets moderate-to-severe #AUD with a differentiated formulation for addiction clinics. #SVN002 #505b2 #Spravato #AddictionTreatment #Solvonis $SVNS" @awakn_ls on X 2025-07-18 09:31:30 UTC 8583 followers, XXX engagements
"AUD is the crisis we keep ignoring 29.5M Americans meet criteria for AUD X% get treatment. SVN002 is our neuroscience-led response: ✔ Novel esketamine therapeutic ✔ Clinic-based ✔ 505(b)(2) path bridging to Spravato #AUD #SVN002 #505b2 #AddictionTreatment #Solvonis" @awakn_ls on X 2025-07-15 09:23:47 UTC 8581 followers, XXX engagements
"Congrats to @SolvonisTx Chair Dennis Purcell on landmark $1.9B @AbbVieIGI deal As a Board Director at IGI he played a key role in one of biotechs biggest licensing agrmnts of 2025 🔹$700M upfront 🔹$1.225B in milestones 🔹Tiered royalties Proud to have him lead Solvonis" @awakn_ls on X 2025-07-14 08:18:29 UTC 8581 followers, XXX engagements
/creator/x::awakn_ls